Differentiated thyroid cancer is increasing in prevalence. This article discusses various aspects of the postoperative management of differentiated thyroid cancer including cancer staging, treatment, and monitoring. Treatment options discussed include radioactive iodine remnant ablation and levothyroxine suppression therapy. Recommendations are given for monitoring based on thyroglobulin determination and available imaging modalities.
机构:
NYU Langone Hlth, Dept Surg, 530 First Ave,12th Floor, New York, NY 10016 USANYU Langone Hlth, Dept Surg, 530 First Ave,12th Floor, New York, NY 10016 USA
Alam, Iram S.
Patel, Kepal N.
论文数: 0引用数: 0
h-index: 0
机构:
NYU Langone Hlth, Fac Dev, Div Endocrine Surg, 530 First Ave,12th Floor, New York, NY 10016 USANYU Langone Hlth, Dept Surg, 530 First Ave,12th Floor, New York, NY 10016 USA
机构:
Royal Brisbane & Womens Hosp, Dept Internal Med & Aged Care, Herston, Qld 4029, Australia
Royal Brisbane & Womens Hosp, Dept Endocrinol, Herston, Qld 4029, Australia
QIMR Berghofer Med Res Inst, Dept Populat Hlth, Herston, Qld 4029, AustraliaRoyal Brisbane & Womens Hosp, Dept Internal Med & Aged Care, Herston, Qld 4029, Australia